45 related articles for article (PubMed ID: 30498011)
1. Hypomethylation of the CTCFL/BORIS promoter and aberrant expression during endometrial cancer progression suggests a role as an Epi-driver gene.
Hoivik EA; Kusonmano K; Halle MK; Berg A; Wik E; Werner HM; Petersen K; Oyan AM; Kalland KH; Krakstad C; Trovik J; Widschwendter M; Salvesen HB
Oncotarget; 2014 Feb; 5(4):1052-61. PubMed ID: 24658009
[TBL] [Abstract][Full Text] [Related]
2. Targeting CTCFL/BORIS for the immunotherapy of cancer.
Loukinov D
Cancer Immunol Immunother; 2018 Dec; 67(12):1955-1965. PubMed ID: 30390146
[TBL] [Abstract][Full Text] [Related]
3. A Therapeutic Vaccine Targeting Rat BORIS (CTCFL) for the Treatment of Rat Breast Cancer Tumors.
Loukinov D; Anderson AL; Mkrtichyan M; Ghochikyan A; Rivero-Hinojosa S; Tucker J; Lobanenkov V; Agadjanyan MG; Nelson EL
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36983050
[TBL] [Abstract][Full Text] [Related]
4. Offline: Boris Johnson and COVID-19-more light than heat.
Horton R
Lancet; 2023 Dec; 402(10419):2277. PubMed ID: 38103935
[No Abstract] [Full Text] [Related]
5. Prof. Boris Sepesi: patient-personalized treatment is the best treatment.
Jia Z; Wu S; Zhong J
J Thorac Dis; 2017 Oct; 9(10):E925-E927. PubMed ID: 29268438
[No Abstract] [Full Text] [Related]
6. Overexpression of cancer-testis antigen melanoma-associated antigen A1 in lung cancer: A novel biomarker for prognosis, and a possible target for immunotherapy.
Fanipakdel A; Seilanian Toussi M; Rezazadeh F; Mohamadian Roshan N; Javadinia SA
J Cell Physiol; 2019 Jul; 234(7):12080-12086. PubMed ID: 30569450
[TBL] [Abstract][Full Text] [Related]
7. ISG20L1 acts as a co-activator of DAPK1 in the activation of the p53-dependent cell death pathway.
Zou S; Zhang C; Xu H; Liu Z; Hu Y; Wang W; Liu K; Wen Q; Song L
J Cell Sci; 2023 Apr; 136(7):. PubMed ID: 36855954
[TBL] [Abstract][Full Text] [Related]
8. Ciliary mechanosensation - roles of polycystins and mastigonemes.
Liu P; Liu Y; Zhou J
J Cell Sci; 2023 Feb; 136(3):. PubMed ID: 36752106
[TBL] [Abstract][Full Text] [Related]
9. Structure and function of distal and subdistal appendages of the mother centriole.
Ma D; Wang F; Teng J; Huang N; Chen J
J Cell Sci; 2023 Feb; 136(3):. PubMed ID: 36727648
[TBL] [Abstract][Full Text] [Related]
10. Scribble and E-cadherin cooperate to control symmetric daughter cell positioning by multiple mechanisms.
Chann AS; Chen Y; Kinwel T; Humbert PO; Russell SM
J Cell Sci; 2023 Jan; 136(2):. PubMed ID: 36661138
[TBL] [Abstract][Full Text] [Related]
11. AMG232 inhibits angiogenesis in glioma through the p53-RBM4-VEGFR2 pathway.
Xiao Y; Li M; Ma T; Ning H; Liu L
J Cell Sci; 2023 Jan; 136(2):. PubMed ID: 36601864
[TBL] [Abstract][Full Text] [Related]
12. The diverse actions of cytoskeletal vimentin in bacterial infection and host defense.
Miao C; Zhao S; Etienne-Manneville S; Jiu Y
J Cell Sci; 2023 Jan; 136(1):. PubMed ID: 36594661
[TBL] [Abstract][Full Text] [Related]
13. The fission yeast kinetochore complex Mhf1-Mhf2 regulates the spindle assembly checkpoint and faithful chromosome segregation.
Jian Y; Nie L; Liu S; Jiang Y; Dou Z; Liu X; Yao X; Fu C
J Cell Sci; 2023 Jan; 136(2):. PubMed ID: 36537249
[TBL] [Abstract][Full Text] [Related]
14. The Plk1 kinase negatively regulates the Hedgehog signaling pathway by phosphorylating Gli1.
Zhang T; Xin G; Jia M; Zhuang T; Zhu S; Zhang B; Wang G; Jiang Q; Zhang C
J Cell Sci; 2019 Jan; 132(2):. PubMed ID: 30578313
[TBL] [Abstract][Full Text] [Related]
15. EGCG protects cardiomyocytes against hypoxia-reperfusion injury through inhibition of OMA1 activation.
Nan J; Nan C; Ye J; Qian L; Geng Y; Xing D; Rahman MSU; Huang M
J Cell Sci; 2019 Jan; 132(2):. PubMed ID: 30518622
[TBL] [Abstract][Full Text] [Related]
16. Higher Expression Levels of
Alrubie TM; Alamri AM; Almutairi BO; Alrefaei AF; Arafah MM; Alanazi M; Semlali A; Almutairi MH
Medicina (Kaunas); 2023 May; 59(5):. PubMed ID: 37241221
[No Abstract] [Full Text] [Related]
17. DDX43 mRNA expression and protein levels in relation to clinicopathological profile of breast cancer.
Amer NN; Khairat R; Hammad AM; Kamel MM
PLoS One; 2023; 18(5):e0284455. PubMed ID: 37200388
[TBL] [Abstract][Full Text] [Related]
18. MAGEA1 inhibits the expression of BORIS via increased promoter methylation.
Zhao J; Wang Y; Liang Q; Xu Y; Sang J
J Cell Sci; 2019 Jan; 132(1):. PubMed ID: 30498011
[TBL] [Abstract][Full Text] [Related]
19. DNA methylation-dependent regulation of BORIS/CTCFL expression in ovarian cancer.
Woloszynska-Read A; James SR; Link PA; Yu J; Odunsi K; Karpf AR
Cancer Immun; 2007 Dec; 7():21. PubMed ID: 18095639
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
